In addition, an oncogene UBE2T promoted cisplatin resistance by inducing protective autophagy in lung cancer cells, and the signature of UBE2T-related autophagy genes showed better prognostic accuracy than UBE2T alone or traditional TNM stage (Zhu et al. 2021a, b). The gene discussed is UBE2T; the disease is lung carcinoma.